Two distinct pathways of p16 gene inactivation in gallbladder cancer

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 47

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

396

HTML

2763

Figures (1-3)

309

Tables (1-5)

166

Sum=3634

Dec 21, 2007 (publication date) through Nov 8, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Dec 21, 2007; 13(47): 6396-6403
Published online Dec 21, 2007. doi: 10.3748/wjg.v13.i47.6396

Table 5 Association between p16 immunohistochemistry and p16 alterations in gallbladder cancers

	p16 immunohistochemistry
	Positive	Negative	P
Retension	3	3
Hypermethyaltion	9	6
LOH	1	3
LOH (multiple) + Hypermethylation	2	8
Multiple LOH	0	3
Homozygous deletion	4	9	P < 0.05

LOH: Loss of heterozygosity; Multiple LOH: LOH in 9p21 at more than two loci.

Citation: Tadokoro H, Shigihara T, Ikeda T, Takase M, Suyama M. Two distinct pathways of p16 gene inactivation in gallbladder cancer. World J Gastroenterol 2007; 13(47): 6396-6403
URL: https://www.wjgnet.com/1007-9327/full/v13/i47/6396.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i47.6396